Managing Mitral Regurgitation in Heart Failure—Perspectives After COAPT
Authors:
- 10 December 2019
- journal article
- research article
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 21 (12) , 86
Abstract
Functional mitral regurgitation (MR) in setting of cardiomyopathy causes significant morbidity and worsened survival. Surgical therapies have failed to demonstrate significant overall benefit for functional MR. More recently, major trials utilizing transcatheter therapies for functional MR have been completed and offer new avenues for intervention. This review evaluates and compares 2 major recent trials designed to test the benefit of edge-to-edge repair using the MitraClip system for severe functional MR.Keywords
This publication has 21 references indexed in Scilit:
- Transcatheter Mitral-Valve Repair in Patients with Heart FailureNew England Journal of Medicine, 2018
- Percutaneous Repair or Medical Treatment for Secondary Mitral RegurgitationNew England Journal of Medicine, 2018
- Survival and Cardiovascular Outcomes of Patients With Secondary Mitral RegurgitationJAMA Cardiology, 2017
- Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk PatientsNew England Journal of Medicine, 2016
- Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral RegurgitationNew England Journal of Medicine, 2016
- Secondary Mitral Regurgitation in Heart FailureJACC, 2015
- Surgical Treatment of Moderate Ischemic Mitral RegurgitationNew England Journal of Medicine, 2014
- Transcatheter Aortic-Valve Replacement with a Self-Expanding ProsthesisNew England Journal of Medicine, 2014
- Transcatheter Aortic Valve Replacement Using a Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at Extreme Risk for SurgeryJACC, 2014
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryNew England Journal of Medicine, 2010